Filter
363
Filtered Results: 363
Text search:
University
of
Liverpool
Featured
Recommendations
57
New Publications
65
Language
Document type
No document type
148
Guidelines
80
Studies & Reports
70
Training Material
28
Manuals
27
Strategic & Response Plan
6
Fact sheets
4
Countries / Regions
Global
13
Africa
10
Uganda
9
Malawi
9
Sierra Leone
8
Kenya
8
Latin America and the Carribbean
7
India
6
Western and Central Europe
6
Nigeria
5
Congo, Democratic Republic of
5
Rwanda
5
Ghana
4
South Africa
4
Brazil
4
Guinea
3
Liberia
3
Ethiopia
3
Nepal
3
Bangladesh
3
Eastern Europe and Central Asia
3
South Sudan
2
Germany
2
Turkey
2
Tanzania
2
Myanmar / Burma
2
Russia
2
North America
2
Spain
2
Burkina Faso
1
Senegal
1
Côte d’Ivoire / Ivory Coast
1
Cameroon
1
Zimbabwe
1
Haiti
1
Zambia
1
Syria
1
Chad
1
Cambodia
1
China
1
Indonesia
1
Mozambique
1
Sudan
1
Namibia
1
Austria
1
Switzerland
1
Ukraine
1
Botswana
1
Angola
1
Lesotho
1
East and Southern Africa
1
West and Central Africa
1
Asia
1
Eastern Europe
1
Italy
1
Qatar
1
Estonia
1
Romania
1
Iran
1
Kyrgyzstan
1
Kazakhstan
1
Vietnam
1
France
1
United Kingdom
1
Portugal
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
84
Countries
60
Women & Child Health
31
Public Health
19
Key Resources
7
Capacity Building
5
Pharmacy & Technologies
5
Toolboxes
Mental Health
58
HIV
48
TB
30
COVID-19
25
Disability
19
NTDs
19
Ebola
15
Planetary Health
15
Caregiver
11
Rapid Response
8
NCDs
8
Global Health Education
7
Zika
6
AMR
5
Conflict
4
Natural Hazards
4
Pharmacy
4
Refugee
2
Social Ethics
2
Polio
1
Health Financing Toolbox
1
A resource for improving menstraul hygiene around the world.
Comprehensive guidance with examples of good practice, information for colleagues and pupils in class and tips on how to break the taboo
Severe bacterial infections are a leading cause of morbidity and mortality among people with advanced HIV disease, after tuberculosis and cryptococcal disease. For countries to reach the end-AIDS targets for 2030, there is a need to establish a road...
The authors state that researchers, governments and global agencies should proceed with particular care in the evaluation of candidate SARS-CoV-2 vaccines in LMICs, with effective communication to build trust and avoid generation ... vaccine hesitancy. Vaccine efficacy is often highly variable between high-resource and low-resource settings
Archives of Disease in Childhood, vol.106 Issue 2
Person-centred recovery planning for mental health and well-being: self-help tool: WHO QualityRights
Ensuring mental health and well-being has become a worldwide imperative and an important target of the Sustainable Development Goals. But in all countries around the world, our response has been woefully insufficient, and we have made
little progre...
Ensuring mental health and well-being has become a worldwide imperative and an important target
of the Sustainable Development Goals.
But in all countries around the world, our response has been woefully insufficient, and we have made
little prog...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment cri...
The Planetary Health Report Card is a student-driven, metric-based initiative to inspire planetary health and sustainable healthcare education engagement in medical schools. In addition to inspiring expansion of medical school curricula, we hope to ...
This Cardiac Rehabilitation Change Package was completed by the Centers for Disease Control and Prevention (CDC) in collaboration with the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) with the purpose ... helping cardiac rehabilitation programs, hospital quality improvement teams, and public health professionals who partner with these groups to implement systems and strategies that improve care for patients who are eligible for cardiac rehabilitation. AACVPR is a multidisciplinary professional association comprised of health professionals who serve in the field of cardiac and pulmonary rehabilitation.
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate ... persons affected by lymphatic filariasis is 25 million men with hydrocele and over 15 million people with lymphoedema. At least 36 million persons remain with these chronic disease manifestations. The disease is endemic in 72 countries. In 2016, an estimated total population of 856 million were living in areas with ongoing transmission of the causative filarial parasites and requiring mass drug administration (MDA). Lymphatic filariasis disfigures and disables, and often leads to stigmatization and poverty. Hundreds of millions of dollars are lost annually due to reduced productivity of affected patients. WHO has ranked the disease as one of the world’s leading causes of permanent and long-term disability.
The plan contains the latest available evidence on the extent of insecticide resistance around the world, and puts forward a strategy for global and country levels, identifying clear roles and timelines for all stakeholders. The GPIRM also summarize...
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB ...
Scabies is a global health concern disproportionately affecting vulnerable populations such as refugees and asylum seekers. Greece is a main point of entry in Europe for refugees, but epidemiological data on scabies in this population are scarce. We...
Background
Asthma education, a key component of long-term asthma management, is challenging in resource-limited settings with shortages of clinical staff. Task-shifting educational roles to lay (no...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-...-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living with HIV who are being treated for tuberculosis.
New recommendations launched today outline key new actions that countries can take to improve the delivery of HIV testing, treatment and care services by providing greater options for differentiated approaches such as, supporting HIV treatment start in the community, ensuring that children are diagnosed and treated early, and that viral load treatment monitoring is more accessible, focused and triggers clinical action
Lancet Planet Health 2022;6: e760–68
The emergence of COVID-19 has drawn the attention of health researchers sharply back to the role that food systems can play in generating human disease burden...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of...
mhGAP is based on evidence-based technical guidelines (4) and provides a set of tools and
training packages to extend service provision. The mhGAP Intervention Guide (mhGAP-IG)
for MNS disorders in non-specialized health settings (8) is a clinical...
Epilepsy: a public health imperative
recommended
This is the first global report on epilepsy summarizing the available evidence on the burden of epilepsy and the public health response required at global, regional and national levels.
The reports highlights major gaps in awareness, diagnosis, t...
This report on progress achieved in the WHO European Region and Member States in implementing the European food and nutrition action plan 2015–2020 presents selected epidemiological data on the nutritional status of populations throughout the Regi...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions ... access to HCV diagnostics and pharmaceutical products, including product pricing, the regulatory environment and patent status, which together shape the national hepatitis response in different settings. It highlights key areas for action by ministries of health and other government decision-makers, pharmaceutical manufacturers and technical partners.
